186 related articles for article (PubMed ID: 15028409)
1. Re: Cancers of the head and neck region in developing countries. Radiother Oncol. 2003 Apr;67(1):1-2.
Gupta T; Laskar SG
Radiother Oncol; 2004 Feb; 70(2):207-8; author reply 208-9. PubMed ID: 15028409
[No Abstract] [Full Text] [Related]
2. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
[TBL] [Abstract][Full Text] [Related]
3. Value of postoperative radiotherapy in patients with pathologic N1 neck disease.
Jäckel MC; Ambrosch P; Christiansen H; Martin A; Steiner W
Head Neck; 2008 Jul; 30(7):875-82. PubMed ID: 18302275
[TBL] [Abstract][Full Text] [Related]
4. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.
Dinshaw KA; Agarwal JP; Laskar SG; Gupta T; Shrivastava SK; Cruz AD
J Surg Oncol; 2005 Jul; 91(1):48-55. PubMed ID: 15999358
[TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer among lifelong never-smokers and ever-smokers: matched-pair analysis of outcomes after radiation therapy.
Chen AM; Chen LM; Vaughan A; Farwell DG; Luu Q; Purdy JA; Vijayakumar S
Am J Clin Oncol; 2011 Jun; 34(3):270-5. PubMed ID: 20622648
[TBL] [Abstract][Full Text] [Related]
6. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
[TBL] [Abstract][Full Text] [Related]
7. In regards to: Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous cell carcinoma of the head and neck by Pradier et al. (Int J Radiat Oncol Biol Phys 2005;63:1368-1377).
Cengiz M; Ozyar E; Genc M
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):955; author reply 955-6. PubMed ID: 16751078
[No Abstract] [Full Text] [Related]
8. [Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
Horiot JC; Bontemps P; Begg AC; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M
Bull Cancer Radiother; 1996; 83(4):314-20. PubMed ID: 9081333
[No Abstract] [Full Text] [Related]
9. Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer.
Widder J; Dobrowsky W; Schmid R; Pokrajac B; Selzer E; Pötter R
Radiother Oncol; 2004 Nov; 73(2):173-7. PubMed ID: 15542164
[TBL] [Abstract][Full Text] [Related]
10. Current trends of surgical management of head and neck carcinomas.
Bauer AM
Nurs Clin North Am; 2001 Sep; 36(3):501-6, x. PubMed ID: 11532664
[TBL] [Abstract][Full Text] [Related]
11. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy.
León X; López M; Piñeiro Z; Langendijk JA; Leemans CR; Quer M
Head Neck; 2007 Sep; 29(9):815-21. PubMed ID: 17405168
[TBL] [Abstract][Full Text] [Related]
12. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
13. [Current trends in head and neck squamous cell carcinomas].
Lacau Saint-Guily J; Périé S
Bull Cancer; 2006 Jan; 93(1):51-9. PubMed ID: 16455506
[TBL] [Abstract][Full Text] [Related]
14. [What makes "Head-and-Neck-Cancers" recur: Tumorinvasion "revisited"].
Simon C; Koitschev A; Plinkert PK
Laryngorhinootologie; 2007 Mar; 86(3):172-5. PubMed ID: 17351878
[TBL] [Abstract][Full Text] [Related]
15. [Microsatellite molecular analysis of the resection margins and laterocervical lymph nodes in the planning of complementary postoperative radiotherapy in early squamous carcinoma (stage I and II) of the head and neck].
Gallo O
Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):383-5. PubMed ID: 11398673
[No Abstract] [Full Text] [Related]
16. Metastatic cutaneous squamous cell carcinoma of the head and neck: the Immunosuppression, Treatment, Extranodal spread, and Margin status (ITEM) prognostic score to predict outcome and the need to improve survival.
Oddone N; Morgan GJ; Palme CE; Perera L; Shannon J; Wong E; Gebski V; Veness MJ
Cancer; 2009 May; 115(9):1883-91. PubMed ID: 19224549
[TBL] [Abstract][Full Text] [Related]
17. Staging of head and neck cancer.
Ennis RD; Knisely JP; Wilson LD
N Engl J Med; 1995 Jun; 332(26):1787-8; author reply 1789-90. PubMed ID: 7619166
[No Abstract] [Full Text] [Related]
18. Treatment results on advanced neck metastasis (N3) from head and neck squamous carcinoma.
Carvalho AL; Kowalski LP; Agra IM; Pontes E; Campos OD; Pellizzon AC
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):862-8. PubMed ID: 15944556
[TBL] [Abstract][Full Text] [Related]
19. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
Forastiere AA
J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
[No Abstract] [Full Text] [Related]
20. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
